CEACAM5 and COVID-19: To further validate the reduced CEACAM5 expression in feces of COVID-19 patients (17) and explore its biological functions, mice models were established through intraperitoneally injecting recombinant viral spike-Fc containing RBD to mimic the intestinal inflammation (Figure 1A) as we previously reported (12).